Legal Opinion
Trivascular, Inc. v. Samuels
Court of Appeals for the Federal Circuit
Decided February 5, 2016No. 2015-1631PublishedCited by 44 opinions
1Opinion of the Court
O’Malley,- Circuit Judge.
TriVascular, Inc. (“TriVascular”) appeals the judgment of the Patent Trial and Appeal Board (“the Board”) holding that TriVascular failed to satisfy its burden of proving that the challenged claims of U.S. Patent No. 6,007,575 (“the '575 patent”) are invalid as obvious. For the reasons below, we affirm.
Background
The '575 patent claims inventions in the field of intraluminal stent technology. One type of intraluminal stent is a vascular stent. Vascular stents are used to treat medical conditions wherein a vascular wall is unduly constricted, as in the case of vascular…
2Cases cited22 opinions
- Consolidated Edison Co. v. National Labor Relations BoardSupreme Court of the United States · 1938
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.Supreme Court of the United States · 2002
17 more not listed; retrieve them via the Exa API.
3Cited by44 opinions
- Massachusetts Institute of Technology v. Shire Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 2016
- In Re Magnum Oil Tools International, Ltd.Court of Appeals for the Federal Circuit · 2016
- In Re: Power Integrations, Inc.Court of Appeals for the Federal Circuit · 2018
- In Re: HodgesCourt of Appeals for the Federal Circuit · 2018
- Arista Networks, Inc. v. Cisco Systems, Inc.Court of Appeals for the Federal Circuit · 2018
39 more not listed; retrieve them via the Exa API.